Myocardial perfusion/metabolism mismatch and ventricular arrhythmias in the chronic post infarction state

B J Krause1, T D Poeppel, M Reinhardt

  • 1Abteilung Nuklearmedizin, Radiologie III, Universitätsklinikum Ulm, Robert-Koch-Strasse 8, 89081 Ulm, Germany. bernd-joachim.krause@medizin.uni-ulm.de

Insights

Myocardial perfusion/metabolism mismatches (MM) are linked to ventricular arrhythmias post-heart attack. Detecting these MM segments identifies patients at higher risk for cardiac events.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Cardiac Electrophysiology

Background:

  • Ventricular arrhythmias often originate in the peri-infarct zone.
  • Hypoperfused but viable myocardium in these areas may contribute to arrhythmia pathogenesis.

Purpose of the Study:

  • To test the hypothesis that myocardial perfusion/metabolism mismatches (MM) are associated with ventricular arrhythmias in the chronic post-infarction state.

Main Methods:

  • 47 post-infarction patients (33 with ventricular arrhythmia, 14 without) underwent (99m)Tc tetrofosmin SPECT and (18)F-FDG PET.
  • Region-of-interest analysis assessed viable myocardium using MM criteria.
  • Univariate and logistic regression analyses were performed.

Main Results:

  • 94% of arrhythmic patients had at least one MM segment vs. 64% of non-arrhythmic patients.
  • MM segments showed a significant relation to arrhythmia (p=0.018).
  • Logistic regression predicted arrhythmia occurrence with 85% accuracy, consistent after multivariate adjustment.

Conclusions:

  • Hypoperfused, viable myocardium is an arrhythmogenic substrate and a risk factor for ventricular arrhythmias post-myocardial infarction.
  • Detecting MM segments aids in identifying high-risk patients for future cardiac events.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...